COPD

Although smoking is a well-known risk factor for lung cancer, the results of a recent study indicate that smokers with chronic obstructive pulmonary disease (COPD) face a significantly higher risk of developing lung cancer than smokers without the respiratory condition.

Patients who live in low-income of rural areas of the United States may face a greater risk of developing chronic obstructive pulmonary disease, according to recent study results presented at the 2015 American Thoracic Society International Conference.

Patients who develop a psychological conditions suck as depression anxiety, psychosis, or alcohol/drug abuse are more likely to be readmitted early to a hospital for complications related to chronic obstructive pulmonary disease, recent study results suggest.

Four specific gut bacteria protect babies from developing asthma.

LQG participants show improvements in lung function, overall health, mental health, and quality of life.

Normal growth in lung function in early adulthood an important factor in terms of future COPD risk.

Depression and smoking status may be valuable targets for interventions from care providers.

Guidelines recommend inhaled corticosteroids for patients who experience repeated COPD exacerbations.

Treating chronic pulmonary obstructive disease with both inhaled corticosteroids and long-acting bronchodilators remains controversial, but new evidence suggests that this controller combination could reduce mortality risk.

Study finds interventions for patients with high anxiety could be beneficial.

Rollator produces highest walk distance and times in COPD patients.

How should you treat this patient?

Caregivers should be mindful of COPD patient-reported symptoms that may lead to hospitalization.

Statins may influence alterations in the airways of asthmatics during restructuring.

Roflumilast has been found to help prevent flare-ups associated with COPD.

Nucala is for use with other asthma drugs for the maintenance of patients 12 years and older.

Health application allows patients to report respiratory symptoms and peak flow measurements from COPD.

Drop in physical activity level linked to increased airflow obstruction.

Drugs are delivered via the low-resistance Neohaler inhaler.

For patients with chronic obstructive pulmonary disease (COPD), fear during episodes of breathlessness, dyspnea during typical daily activities, and depressive symptoms may be good predictors of hospitalization.

The FDA has approved 2 Novartis inhalation powders for the treatment of COPD.

Caregivers are urged to utilize adequate mental health screening approaches.

Process can improve medical care with better results for patients.

Community level factors linked to COPD include rural residence, southern residence, and community poverty.

Grants expected to lead to development of wearable and non-wearable sensors to track environmental exposures and physiological signals in a natural environment.

Vitamin D deficiency may speed progression of the condition.

Roflumilast normally treats inflammatory lung diseases, but was found to dramatically inhibit tumor growth.

Inpatient hospitalization and emergency department visits are key cost drivers for patients.

Asthma and chronic obstructive pulmonary disease (COPD) occur together at an alarming rate.

Childhood pneumonia carries a higher risk of chronic bronchitis and other disease-related quality of life issues.